Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
123606902 | 12360690 | 2 | F | 20160415 | 20160909 | 20160512 | 20160920 | EXP | US-ELI_LILLY_AND_COMPANY-US201605002820 | ELI LILLY AND CO | 53.34 | YR | F | Y | 0.00000 | 20160920 | OT | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
123606902 | 12360690 | 1 | PS | ADCIRCA | TADALAFIL | 1 | Oral | 20 MG, UNKNOWN | U | U | 21368 | 20 | MG | TABLET | |||||
123606902 | 12360690 | 2 | SS | ADCIRCA | TADALAFIL | 1 | Oral | 20 MG, 2 PILLS/DAY | U | U | 21368 | 20 | MG | TABLET |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
123606902 | 12360690 | 1 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
123606902 | 12360690 | DE |
123606902 | 12360690 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
123606902 | 12360690 | Death | |
123606902 | 12360690 | Hypoxia | |
123606902 | 12360690 | Infection | |
123606902 | 12360690 | Pneumonia | |
123606902 | 12360690 | Sickle cell anaemia with crisis |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
123606902 | 12360690 | 2 | 20160909 | 0 |